ABBV - Syros jumps on FDA fast track tag for leukemia drug
2024-04-09 11:00:51 ET
More on Syros Pharmaceuticals
- Syros Pharmaceuticals, Inc. (SYRS) Q4 2023 Earnings Call Transcript
- Syros Pharmaceuticals: Rising Despite Dilution, A Must Look
- Syros Pharmaceuticals GAAP EPS of -$2.18 misses by $1.04, revenue of $0.4M misses by $1.6M
- Seeking Alpha’s Quant Rating on Syros Pharmaceuticals
- Historical earnings data for Syros Pharmaceuticals